These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21054778)

  • 1. Decrease in serum adiponectin levels in response to treatment predicts good prognosis in acute decompensated heart failure.
    Matsumoto M; Lee-Kawabata M; Tsujino T; Naito Y; Ezumi A; Sakoda T; Ohyanagi M; Shimomura I; Masuyama T
    J Clin Hypertens (Greenwich); 2010 Nov; 12(11):900-4. PubMed ID: 21054778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Endoplasmic Reticulum Stress Markers in Low Ejection Fractional Heart Failure.
    Sabirli R; Koseler A; Mansur N; Zeytunluoglu A; Sabirli GT; Turkcuer I; Kilic ID
    In Vivo; 2019; 33(5):1581-1592. PubMed ID: 31471408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus.
    Yamaji M; Tsutamoto T; Tanaka T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ J; 2009 Dec; 73(12):2264-9. PubMed ID: 19797823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Change in Serum Chloride During Hospitalization Could Predict Heart Failure Death in Acute Decompensated Heart Failure Patients.
    Kondo T; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Ozaki T; Sato Y; Seo M; Ikeda I; Fukuhara E; Abe M; Nakamura J; Sakata Y; Fukunami M
    Circ J; 2018 Mar; 82(4):1041-1050. PubMed ID: 29467355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.
    Ohara T; Hashimura K; Asakura M; Ogai A; Amaki M; Hasegawa T; Kanzaki H; Sonoda M; Nishizawa H; Funahashi T; Kitakaze M
    J Cardiol; 2011 Sep; 58(2):181-90. PubMed ID: 21824750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of red blood cell distribution width during hospitalization predicts mortality in patients with acute decompensated heart failure.
    Uemura Y; Shibata R; Takemoto K; Uchikawa T; Koyasu M; Watanabe H; Mitsuda T; Miura A; Imai R; Watarai M; Murohara T
    J Cardiol; 2016 Mar; 67(3):268-73. PubMed ID: 26140955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
    J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of admission liver stiffness on long-term clinical outcomes in patients with acute decompensated heart failure.
    Omote K; Nagai T; Asakawa N; Kamiya K; Tokuda Y; Aikawa T; Fukushima A; Noguchi K; Kato Y; Komoriyama H; Nishida M; Kudo Y; Iwano H; Yokota T; Anzai T
    Heart Vessels; 2019 Jun; 34(6):984-991. PubMed ID: 30523443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Serum Sodium Level Within the Low-Normal Range on Admission and Long-Term Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    Hiki M; Kasai T; Yatsu S; Murata A; Matsumoto H; Kato T; Suda S; Miyazaki T; Takagi A; Daida H
    Int Heart J; 2018 Sep; 59(5):1052-1058. PubMed ID: 30101847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure.
    Popovic B; Zannad F; Louis H; Clerc-Urmès I; Lakomy C; Gibot S; Denis CV; Lacolley P; Regnault V
    Int J Cardiol; 2019 Jan; 274():195-201. PubMed ID: 30089551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
    Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation.
    Khan RS; Kato TS; Chokshi A; Chew M; Yu S; Wu C; Singh P; Cheema FH; Takayama H; Harris C; Reyes-Soffer G; Knöll R; Milting H; Naka Y; Mancini D; Schulze PC
    Circ Heart Fail; 2012 May; 5(3):340-8. PubMed ID: 22379072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worsening renal function in patients admitted with acute decompensated heart failure: incidence, risk factors and prognostic implications.
    Belziti CA; Bagnati R; Ledesma P; Vulcano N; Fernández S
    Rev Esp Cardiol; 2010 Mar; 63(3):294-302. PubMed ID: 20196990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
    Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y
    Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Fractional Excretion of Urea Nitrogen at Discharge in Acute Decompensated Heart Failure.
    Nogi K; Kawakami R; Ueda T; Nogi M; Ishihara S; Nakada Y; Hashimoto Y; Nakagawa H; Nishida T; Seno A; Onoue K; Soeda T; Watanabe M; Saito Y
    J Am Heart Assoc; 2021 Aug; 10(16):e020480. PubMed ID: 34369200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of mortality in patients with heart failure after de-compen-sation during long-term follow-up in specialized medical care and in real clinical practice].
    Vinogradova NG; Polyakov DS; Fomin IV
    Kardiologiia; 2020 Mar; 60(4):91-100. PubMed ID: 32394863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.